Quick Stats
50.0
AI Score
HOLD0.05
Volume Ratio
Next Earnings
1
+ve Days (30d)
1
-ve Days (30d)
LIFE Stock Summary
Last updated
LIFE is currently trading at $15.185, positioned below its 200-day moving average of $, suggesting bearish momentum. The stock has a 52-week range of $15.05 to $19.
Technical Analysis: The 50-day moving average stands at $, which is above the current price, indicating bearish near-term pressure. The RSI (Relative Strength Index) reads , suggesting the stock is neutral with balanced momentum.
Money Flow Indicators: The Chaikin Money Flow (20-day) is , which is negative, suggesting distribution or selling pressure. Our AI-powered investment score rates LIFE at 50.0/100 with a HOLD recommendation.
LIFE Technical Chart
- Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
- SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
- Options OI: Shows max open interest strikes. High OI = significant price levels.
- Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
- Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
- Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
- Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
- Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Select indicators above to analyze technical patterns
Indicators will appear below the price chart with perfectly aligned datesVolume Profile Analysis
Horizontal histogram showing volume distribution at each price level with buying/selling pressure
LIFE Price vs Max Options Open Interest
LIFE Max Change In Options Open Interest
LIFE Options - Sort by Max open Interest (near term)
2nd February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
LIFE Daily Out of Money Options - Sort by Max open Interest (near term)
2nd February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
LIFE Daily In the Money Options - Sort by Max open Interest (near term)
2nd February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
LIFE Most Active Options by Volume(near term)
2nd February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | Volume | OI | Change in OI |
Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
None is not trading above both 50 Day and 200 Day SMA which is considered Bearish.
LIFE Moving Averages Analysis
LIFE (None) Simple Moving Averages
Moving Averages are last updated
| Days | MA |
|---|
This thread discusses the unmet medical need for sarcoidosis and the low success rate of steroids as the only option. The company $LIFE has received $20 million from its Japanese partner Kyorin and is eligible to receive additional funding. Data review has shown that the drug ATYR1923 is safe and has a 58% reduction in steroid use from baseline and 22% relative reduction. There has also been a clinically meaningful improvement in dyspnea, cough, and fatigue. The company has been granted U.S. and E.U. orphan drug and U.S. Fast Track designations. The author has accumulated a significant position around $1.7 and is planning to add dips based on market sentiment.
Updated 2023-04-22 22:40:02